Marth William S
Insider CIK 1549936 · AMRI President and CEO, Director · TLGT Director · SRNE Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TLGT Teligent, Inc. | A Award deriv | 2021-07-21 | 2021-07-22 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TLGT Teligent, Inc. | A Award deriv | 2021-02-16 | 2021-02-24 | 2,000 | — | $0 | 2,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | D To issuer deriv | 2017-08-31 | 2017-09-05 | 54,498 | $5.98 | $325.9K | 0 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | D To issuer deriv | 2017-08-31 | 2017-09-05 | 133,690 | $3.34 | $446.5K | 0 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | J Other | 2017-08-31 | 2017-09-05 | 20,383 | — | $0 | 483,033 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | J Other | 2017-08-31 | 2017-09-05 | 18,472 | — | $0 | 503,416 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | D To issuer | 2017-08-31 | 2017-09-05 | 483,033 | $21.75 | $10.51M | 0 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2017-07-05 | 2017-07-06 | 884 | $16.04 | $14.2K | 521,888 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2017-02-08 | 2017-02-10 | 133,690 | — | $0 | 133,690 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2017-02-08 | 2017-02-10 | 27,159 | — | $0 | 500,621 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2017-02-08 | 2017-02-10 | 20,383 | — | $0 | 521,004 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2017-02-04 | 2017-02-07 | 41,626 | $18.52 | $770.9K | 475,404 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2017-02-04 | 2017-02-07 | 1,942 | $18.52 | $36.0K | 473,462 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2017-01-01 | 2017-01-03 | 8,425 | $18.63 | $157.0K | 517,030 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2016-07-11 | 2016-07-12 | 49,000 | — | $0 | 182,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2016-07-05 | 2016-07-07 | 1,312 | $11.42 | $15.0K | 525,455 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2016-05-16 | 2016-05-16 | 12,500 | $12.86 | $160.8K | 524,143 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2016-02-04 | 2016-02-08 | 54,498 | $15.77 | $859.4K | 54,498 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2016-02-04 | 2016-02-08 | 71,338 | $15.77 | $1.13M | 510,178 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2016-01-06 | 2016-02-08 | 490 | $16.79 | $8.2K | 510,668 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2016-01-01 | 2016-01-04 | 8,374 | $20.16 | $168.8K | 438,840 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2015-06-04 | 2015-06-08 | 58,000 | — | $0 | 133,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2015-06-04 | 2015-06-08 | 10,000 | $19.98 | $199.8K | 447,214 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | M Exercise deriv | 2015-04-07 | 2015-04-08 | 12,367 | — | $0 | 0 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | M Exercise deriv | 2015-04-07 | 2015-04-08 | 10,000 | — | $0 | 0 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | M Exercise | 2015-04-07 | 2015-04-08 | 10,000 | $2.59 | $25.9K | 424,847 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | M Exercise | 2015-04-07 | 2015-04-08 | 12,367 | $5.99 | $74.1K | 437,214 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2015-03-05 | 2015-03-06 | 20,000 | $17.70 | $354.0K | 414,847 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2015-03-02 | 2015-03-04 | 58,651 | $17.05 | $1000.0K | 393,907 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2015-01-22 | 2015-03-04 | 940 | $13.84 | $13.0K | 394,847 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2015-01-01 | 2015-01-05 | 8,443 | $16.10 | $135.9K | 335,256 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2014-11-10 | 2014-11-10 | 30,000 | $17.01 | $510.3K | 343,699 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2014-09-18 | 2014-09-22 | 25,000 | — | $0 | 75,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2014-05-12 | 2014-05-13 | 30,000 | $15.40 | $462.0K | 313,699 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2014-02-04 | 2014-02-06 | 95,238 | $10.50 | $1000.0K | 283,699 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | F Tax w/h | 2014-01-31 | 2014-02-04 | 1,905 | — | $0 | 188,461 | SEC↗ |
| SRNE Sorrento Therapeutics, Inc | A Award deriv | 2014-01-23 | 2014-01-24 | 37,000 | — | $0 | 50,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2014-01-01 | 2014-01-03 | 99,207 | $10.08 | $1.00M | 190,366 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2013-12-03 | 2013-12-04 | 30,000 | $10.75 | $322.5K | 91,159 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2013-11-22 | 2013-11-22 | 20,000 | $11.57 | $231.4K | 61,159 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2013-06-05 | 2013-06-06 | 2,868 | $10.46 | $30.0K | 41,159 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2013-06-03 | 2013-06-04 | 10,000 | $10.23 | $102.3K | 38,291 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2013-06-03 | 2013-06-06 | 10,000 | $10.23 | $102.3K | 38,291 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2013-01-31 | 2013-02-04 | 12,367 | $5.99 | $74.1K | 12,367 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2013-01-31 | 2013-02-04 | 5,843 | $5.99 | $35.0K | 28,291 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | P Buy | 2012-12-03 | 2012-12-04 | 10,000 | $5.00 | $50.0K | 22,448 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award deriv | 2012-06-13 | 2012-06-14 | 10,000 | $2.59 | $25.9K | 10,000 | SEC↗ |
| AMRI ALBANY MOLECULAR RESEARCH | A Award | 2012-06-06 | 2012-06-07 | 12,448 | $2.41 | $30.0K | 12,448 | SEC↗ |